As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, ...

Canaccord Genuity revised its stock price target for Health Catalyst Inc. (NASDAQ:HCAT) shares, reducing it to $10 from the ...

When Health Catalyst begins working with a hospital system, it makes a sweet offer: Move your engineers over to the Utah-based software firm, and they’ll keep your data running and analyzable it ...

Canaccord lowered the firm’s price target on Health Catalyst (HCAT) to $10 from $11 and keeps a Buy rating on the shares. The firm noted the ...

In a report released today, Stan Berenshteyn from Wells Fargo maintained a Buy rating on Health Catalyst (HCAT – Research Report), with a price ...

On Friday, Health Catalyst Inc (HCAT) stock saw a decline, ending the day at $5.49 which represents a decrease of $-0.01 or -0.18% from the prior close of $5.5. The stock opened at $5.53 and touched a ...

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price decreased by Royal Bank of Canada from $9.00 to $7.00 in a research note released on Wednesday morning,Benzinga reports. Royal Bank of ...

He hatched Commure inside General Catalyst in 2017 alongside former leaders from Google, Salesforce, and healthcare data analytics firm Health Catalyst. In a Medium post announcing Commure's ...